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ABSTRACT 
This qualitative study using a phenomenological design, aimed at exploring and 
describing and exploring the experiences of HIV positive clients defaulting Isoniazid 
Preventive Therapy services in the Bhisho Primary Health Care Services. The emphasis 
was on the factors leading clients to default. 
An in- depth unstructured face to face interviews were done on 14 participants from 4 
clinics or facilities under Bhisho Primary Health Care Services. From the respondents’ 
responses it can be noted that work and family related issues, ignorance of patients, 
side effects, and negligence of nurses and denial of HIV status were identified as 
reasons for defaulting. Having knowledge about the treatment and health providers’ 
attitudes to patients also played a role in patients defaulting their treatment. 
 Many suggestions were then put forward by the respondents to curb defaulting among 
patients. These included the use of text message reminders, not to discrimination HIV 
patients because of their status, to use consulting rooms for privacy and also nurses 
and caregivers to control their attitudes when dealing with patients. 
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CHAPTER 1 
INTRODUCTION 
1.1 Background 
 
Preventive therapy (PI) against tuberculosis is defined as the use of one or more anti- 
tuberculosis drugs given to individuals with latent Mycobacterium tuberculosis infection 
to prevent progression to an active disease. HIV infection is the most powerful risk 
factor for the progression of tuberculosis from latent infection to an active disease. HIV 
infection is said to be the major cause of the large increase in the incidence of TB in any 
population with a high HIV prevalence over the past decade (WHO, 2009:3). 
According to the (Department of Health, 2010:3), the dramatic spread of the HIV 
epidemic throughout sub-Saharan Africa in the past decade has been accompanied by 
a fourfold increase in the number of TB cases registered by National TB programmes. 
Strategies to control TB must now include interventions to reduce HIV infection. 
It is estimated that around 70% of new adult cases of TB in South Africa are co-infected 
with HIV (DoH, 2010:3). Tuberculosis is the most common cause of morbidity and 
mortality among HIV-infected persons in South Africa and studies have shown that TB 
accelerates HIV disease progression. Therefore, TB preventive therapy among HIV-
infected persons should be offered to people living with HIV and AIDS.  
The DoH (2010:3) mentions that within the trials done, they have shown that maximum 
benefits from TB preventive therapy are achieved in HIV-infected persons with evidence 
of tuberculosis infection as demonstrated by a positive tuberculin skin test. In these 
patients, the risk of developing TB is prolonged. However, benefits have also been 
shown among HIV-infected person in general, regardless of their tuberculin test results.  
It is essential to exclude active TB in every client prior to starting IPT. This is crucial in 
order to avoid giving one anti TB drug (monotherapy) to clients with TB disease who 
require a full treatment regimen (DoH, 2010:3).   
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When HIV positive clients visit a clinic they are screened for active TB. If there are no 
signs and symptoms of TB, they are treated with isoniazid 300mg, daily for 6 months as 
prophylactic treatment (DoH, 2010:3). 
Despite this preventive therapy, most HIV positive clients on INH (Isoniazid) prophylaxis 
do not visit the health centers for their follow up treatment, and a number of HIV positive 
clients still die of TB, as indicated in Buffalo City Metropolitan Quarterly Review, 2013.  
1.2. Problem statement 
 
Tuberculosis is the most common cause of morbidity and mortality among HIV-infected 
persons in South Africa. Studies have shown that TB accelerates HIV disease 
progression. Therefore, TB preventive therapy should be offered to people living with 
HIV and AIDS. While TB preventive therapy may not reduce the incidence of 
tuberculosis in the community, but it can prevent morbidity and mortality attributable to 
TB at an individual level (DoH, 2010:3). 
The researcher has observed that according to the records and the information given at 
the HIV data verification meetings for the Bhisho sub-sub district that these clients are 
not returning for the prophylactic treatment (Data unpublished, Buffalo City Metropolitan 
Municipality Quarterly Reviews, 2013). The concern of the researcher is that these 
clients are likely to develop TB and resistance to TB drugs containing Isoniazid. This 
can also lead to Multi Drug Resistance (MDR) or Extensive drug resistance (XDR) TB. 
This will increase mortality rate due to TB in spite of the TB programmes which are 
aiming at decreasing TB mortality rates. 
The researcher had decided to undertake this study because the experiences of these 
clients may indicate the reasons for them to default TB prophylactic treatment. 
Furthermore, these reasons might provide new strategies for improving adherence of 
Isoniazid Preventive Therapy. 
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1.3  Aim of the study 
The aim of the study was to explore and describe the experiences of HIV positive clients 
defaulting IPT services at the Bhisho Primary Health Care Services with the aim of 
recommending possible strategies that can be used to prevent isoniazid default.   
1.4  Research objectives 
 
The objectives of this study were: 
 To explore and describe the experiences of HIV positive clients defaulting IPT in 
Bhisho Primary Health Care Services  in the Eastern Cape Province. 
 To determine possible strategies that can be used to prevent isoniazid (INH) 
default at the Bhisho Primary Health Care Services.   
1.5  Research questions 
The research questions for this study were: 
 What are the experiences of the HIV positive clients defaulting IPT at the Bhisho 
Primary Health Care Services of the Eastern Cape Province?    
 Which strategies can be used to prevent Isoniazid (INH) default at the Bhisho 
Primary Health Care Services?  
1.6 Significance of the study 
 
The benefits of the study may be the improvement of the adherence to IPT services. 
This may decrease the morbidity and mortality rates of HIV positive clients by 
maintaining clients with no signs and symptoms of TB. The policy makers may improve 
the policies with regards to IPT service management. 
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The research might also help to reduce the financial burden of TB drugs on the 
country’s economy. These recommendations could provide policy makers with 
information to inform TB control services which could improve adherence. Currently 
there is no known indicator to monitor defaulter rate of Isoniazid in the District Health 
Information System. The department may also appreciate the benefit of having the 
defaulter rate of ionized monitored in HIV positive clients. 
1.7 Research methodology 
In this chapter a brief discussion on research methodology applied as provided, a more 
in- depth approach is described in chapter 3. 
1.7.1 Research design 
 
In this study, a qualitative approach with a phenomenological design was used. The 
design used is descriptive and exploratory in nature and it aimed at exploring the 
experiences of HIV positive clients on IPT regarding Isoniazid Preventive Therapy in 
King Williams Town area under the Buffalo City Municipality in the Eastern Cape 
Province. 
1.7.2 Study population 
 
The population for the study was all HIV positive clients defaulting IPT at Bhisho 
Primary Health Care Services in King William’s Town. 
1.7.3 Target population 
Target population for this study was all HIV positive clients defaulting IPT at Tyutyu, 
Ginsberg, Bhisho Gateway and Sweetwater clinics. 
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1.7.4 Sampling 
 
The researcher used the non-probability sampling with a purposive method. The client 
records available at the clinics from 2000 – 2014 were used to identify the clients that 
defaulted in the IPT program as the sample. The intention of the researcher was to 
interview at least 15 clients although data saturation was reached at 14 clients. 
1.7.4.1 Inclusion criteria 
 
Human- Immuno – Deficiency Virus (HIV) positive clients, males and females between 
the ages of 18 and 40 years with negative smear TB sputum, defaulting IPT, mentally 
stable and willing to participate in the research study were included in the study. 
1.7.4.2 Exclusion criteria 
 
In the study the researcher excluded HIV positive clients with positive smear TB 
sputums, children, those with psychiatric diseases and HIV positive with dementia. 
1.7.5 Pilot study 
 
According to Polit and Beck (2008:761), a pilot study is a small scale, or trial run, done 
in preparation for a major study. 
A pilot study was conducted at Breidbach clinic using HIV positive clients, males and 
females between the ages of 18 and 40 years with negative smear TB sputum, 
defaulting IPT, mentally stable and willing to participate in the research study.  
 The number of participants involved in the pilot study was six (6). They were 
interviewed using the interview guide. Probing questions were guided by the client’s 
responses.  
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Pilot study was conducted to assist the researcher to master interviewing skills and to 
check the relevance and the effectiveness of the interview guide (Polit & Beck, 
2008:761). 
1.7.6 Data Collection 
The method of data collection for this study was an in-depth unstructured face to face 
interview. In-depth interviews allow the participants to describe their lived experiences 
and the meaning of events taking place in their lives. An interview guide was used to 
conduct the interview. The participants were asked questions and probing questions 
depended upon their responses to the main questions (Brink, 2009:70). 
An audio tape-recorder was used to obtain the information from the participants and a 
notebook pad was used for field notes. Data was transcribed verbatim from the audio 
tape. A good working relationship with the participants was developed. Trust and 
rapport was attained by using sound communication skills, empathy and genuine 
acceptance (Brink, 2009:70). 
 1.7.7 Data analysis 
 
Brink (2009:70) maintains that data analysis entails categorizing, ordering, 
manipulating, summarizing the data and describing them in meaningful terms. 
 After each interview with a participant data was transcribed then  analyzed by listening 
to the tapes again and again to gain full understanding of what the participant was 
saying and noting down important points such as pauses of the client, highs and low, 
when she/he sighed. This attributed meaning and assisted the researcher to interpret 
what the phenomena meant. During this process themes were generated (Brink, 
2009:70). 
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1.7.8 Trustworthiness 
Trustworthiness is a way of ensuring data quality, based on the model of Lincoln and 
Guba (1985).Holloway (2008) identified the following principles to demonstrate the 
trustworthiness of the research. 
1.7.8.1 Conformability 
To address the matter of accuracy and appropriateness of data, the researcher used 
conformability by going back to the participants with the data and findings as a means of 
checking the trustworthiness of the data. This afforded an opportunity to ascertain 
factual accuracy and also confirmed or disconfirmed the researchers’ understanding by 
the participants. 
1.7.8.2 Credibility 
To ensure credibility, each person who was approached was given an opportunity to 
refuse to participate in the study. This ensured that the data collection sessions involved 
only those who were genuinely willing to take part and were prepared to offer data 
freely.  
1.7.8.3 Dependability 
This study safeguarded dependability by ensuring that the process within the study was 
reported in detail, thereby enabling a future researcher to repeat the work and to obtain 
similar results. The research design may be viewed as a “prototype model” so as to 
enable readers of the research report to develop a thorough understanding of the 
methods and their effectiveness (Shenton, 2004:66). 
1.7.8.4 Transferability 
Transferability refers to the ability to apply the findings in other context or to other 
participants (Brink, 2012:173). It is also called “fittingness” which refers to the probability 
that the findings have the same meaning to others in similar situations (Speziale & 
Carpenter, 2011:97). The researcher chose purposive sampling consisting of HIV 
positive clients defaulting Isoniazid Preventive Therapy, the clients were from different 
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clinics, different ages and different back grounds. Description of the research 
methodology was done, setting the context of research and literature control. 
1.7.9 Ethical considerations 
 
The researcher in this study ensured that ethics were considered, that the rights of the 
subjects are not infringed. Informed consent forms were obtained before the research 
began. Formal ethical clearance from the University of Fort Hare Ethical Committee and 
approval from the Department of Health was obtained. It was ensured that no research 
processes infringed on the human rights or revealed the confidential nature of the 
individual participation (Wisker, 2008:86). 
Wisker also mentions that ethical guidelines insist that researchers should not do 
physical or psychological harm and that, where human subjects are involved, the 
participants should give their fully informed consent before taking part. Even though 
participants gave consent initially they should be able to withdraw at any time and to 
deny the use of their information in the research (Wisker, 2008:87). That is why the 
participants were given an information sheet with all the information such as the 
purpose of the study, procedures, risks involved, benefits of the study to the participants 
and their rights to withdraw, at any time, from the study. The information sheet, consent 
forms were available in English, Xhosa and in Afrikaans. As the participants are HIV 
positive on IPT and knowing that HIV/AIDS is a sensitive topic, the interviews were 
conducted in privacy. Counseling support was available for the participants as the 
researcher is a professional nurse trained in counseling.  
1.7.10 Dissemination and implementation of results 
 
After the report has been completed it was submitted to the University of Fort Hare 
Nursing Science Department and then to the University’s library. The results will then be 
sent to the Department of Health’s Research Office and to the Management of the 
Buffalo Metropolitan Municipality. 
14 
 
Research articles from the study will be published in accredited nursing journals 
nationally and internationally.  Research papers and posters will be presented in 
conferences and symposia. 
1.8 Definition of terms 
 
Isoniazid Preventive Therapy (IPT) - Refers to a use of one or more anti-TB drugs 
given to individuals with latent mycobacterium tuberculosis infection to prevent the 
progression to an active disease (DoH, 2010:71). 
Isoniazid (INH) – an antibacterial drug, CHNO, used in treating and preventing 
tuberculosis Isoniazid (INH) – an antibacterial drug, CHNO, used in treating and 
preventing tuberculosis (DoH, 2010:71) . 
 HIV- (Human- Immuno-Deficiency- Virus).  
HIV Positive clients – In this study if refers to those who have had a positive result in a 
blood test for the AIDS virus HIV. 
Active TB – means a disease that is caused by mycobacterium tuberculosis or other 
members of the mycobacterium tuberculosis complex family in any part of the body and 
that is in an active state as determined by either (DoH, 2010:3). 
 A smear or culture taken from any source in the person’s body test positive for 
TB and the person has not completed the appropriate prescribed course of 
medication for active TB disease. 
 Radiographic, current clinical or laboratory evidence is sufficient to support a 
medical diagnosis of TB for which treatment is indicated (DoH, 2010:3). 
Adherence to treatment - It is the following of a recommended course of treatment by 
taking all prescribed medication for the length of time necessary (DoH, 2010:3). In this 
study it will mean the taking of isoniazid 300 mg daily for a period of six months. 
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Treatment Default – It is the interruption of IPT for more than 2 consecutive months 
(DoH, 2010:4). 
Experiences – Practical contact with and observation of facts or events. 
Extensive Drug Resistant (XDR-TB) - Refers to a situation in which there is a 
resistance in vitro to isoniazid and rifampicin and any one or more of the second line 
drugs (DOH, 2010:4). 
Latent TB infection – those infected with mycobacterium tuberculosis but do not have 
TB disease. 
Multidrug Resistance Tuberculosis (MDR-TB) - Refers to a tuberculosis disease 
caused by strains of mycobacterium tuberculosis that are resistant to both rifampicin 
and isoniazid with or without resistance to other drugs (DoH, 2009:83). 
Mycobacterium Tuberculosis - Refers to a micro-organism responsible for causing 
Tuberculosis (DoH, 2010:3). 
 
1.9 CONCLUSION 
In this chapter the scientific foundation of the study was introduced with a brief 
description of the rationale and background, problem statement, purpose, objectives, 
research questions, significance of the study and the definition of terms.  
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 Introduction 
The purpose of this study was to explore and describe the experiences of HIV positive 
clients defaulting Isoniazid prophylaxis. This chapter will provide a review of related 
literature. The purpose of a literature review is to place the study in the context of the 
general body knowledge. This minimises the possibility of unintentional duplication and 
increases the probability that the new study makes a valuable contribution (Brink, 
2009:68). 
Literature review generates a picture of both what is known and unknown about the 
research problem. It is essential for the researcher to conduct a literature review in 
order to locate existing, similar or related studies that can serve as a basis for the study 
at hand (Brink, 2009:52). 
For this study a cursory literature review was done to ensure necessity of the study and 
the appropriateness of the research method selected. An in-depth literature review was 
done after data analysis to place the findings within the context of what is already 
known about the topic. The researcher consulted several sources, including medical 
text books, medical and research journals, policies and guidelines.  
Tuberculosis is a major cause of illness and death in people living with HIV, even in 
those taking antiretroviral therapy. Tuberculosis could be prevented in millions of people 
infected with HIV through the use of Isoniazid Preventive Therapy. IPT is an important 
intervention for preventing and reducing active TB. It can prevent millions of people from 
being   infected with TB in the community and in the health care services. 
 IPT is part of the package of care delivered by HIV and TB service providers for people 
living with HIV and their families. It is also one of the key interventions recommended by 
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WHO in 1998 to reduce the burden of TB in people living with HIV, yet its 
implementation has been very slow. Only 25 000 people living with HIV worldwide were 
reported to have received it in 2005 
Human immunodeficiency virus (HIV) associated Tuberculosis (TB) remains a major 
global public health challenge. By the end of 2009, an estimated 33.3 million people 
were living with HIV, the vast majority in Sub- Saharan Africa and Asia. An estimated 
2.6 million individual had become newly infected with HIV and 1.8 million had died of 
AID in that year alone (Padmapriyadarsini et al ,2011:160). 
The estimates of the global burden of disease caused by TB in 2009 were 9.4 million 
incident cases, 1.3 million deaths among HIV negative TB patients and 0.38 million 
deaths among HIV positive TB patients. Most of TB cases were in the South East Asia, 
African and Western Pacific regions. Tuberculosis may occur at any stage of the HIV 
diseases and is frequently the first recognised presentation of underlying HIV infection. 
As compared to people without HIV, people living with HIV have a 20 fold higher risk of 
developing TB and the risk continues to increase as CD4 counts progressively decline 
alone (Padmapriyadarsini et al 2011:160).  It is estimated that around 70% of new adult 
cases of TB in South Africa in the Eastern Cape Province are co- infected with HIV and 
46.6% in the Buffalo City Metropolitan District, according to the Buffalo City Metropolitan 
Quarterly Reviews, 2013. 
In 1993, the WHO first issued a policy statement that recognised the efficacy of TB 
preventive therapy and recommended targeting IPT in PLHIV. That was also the year 
when TB was declared a global emergency. It was also packaged as one of the 12 
collaborative TB/HIV activities recommended by WHO in 2004 and was repackaged as 
part of the three I’s for HIV/TB (Isoniazid preventive treatment, infection control for TB, 
and intensified case- finding) in 2008. World Health Organization also revised its policy 
on IPT in 2010 reiterating the importance of IPT as a core function of services provided 
to PLHIV and as a primary responsibility of National AIDS programs (Getahum, 
Granich, Sculier, Gunneberg, Blanc, Nunn & Raviglione, 2010:240). 
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To reduce the morbidity and mortality from TB in people living with HIV, The World 
Health Organisation recommends the following interventions: early provision of 
antiretroviral therapy (ART) , at CD4 count  less than 350 cells/mm3 and the three I’s for 
HIV and TB: intensified case- finding of TB (ICF), IPT, and infection control for TB (IC). 
Intensified Case Finding and treatment of TB interrupts transmission of diseases by 
infectious cases, decreases morbidity and delays mortality. Most importantly, active TB 
screening offers the opportunity to provide preventive therapy for people who do not 
have symptoms and signs of TB. The WHO Guidelines for intensified TB case- finding 
and Isoniazid Preventive Therapy for people living with HIV in resource- constrained 
settings provide guidance to national HIV and TB programmes and to HIV service 
providers to scale- up the implementation of TB  screening and IPT (Sculier  & Getahum 
, 2011). 
 
Table 1: The WHO (2003) Interim Policy of reducing the joint burden of HIV and TB 
Prevent TB in people living with HIV 
 
 TB infection control in health care 
and congregate settings 
 Intensified TB case finding 
 Isoniazid preventive treatment 
 Scale-up of antiretroviral treatment 
 
Treat HIV in patients with TB 
 
 HIV testing and counseling 
 Cotrimoxazole preventive treatment 
 Antiretroviral treatment 
 
Establish collaboration between HIV and 
TB programmes 
 
 Activities include setting up 
coordinating bodies at all levels, 
surveillance of HIV prevalence in 
TB patients, joint planning and 
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resource mobilization, training, 
supervision, monitoring and 
evaluation 
 
 
2.2 Isoniazid Preventive Therapy 
 
Isoniazid preventive therapy (IPT) is the provision of the drug isoniazid to people at high 
risk of developing active tuberculosis (TB). Those with HIV are 20 to 37 times more 
likely to develop active TB from latent TB than those without HIV, making HIV infection 
the strongest risk factor for TB (DoH, 2010:5). 
South Africa has had national guidelines for administering IPT since 2002, but coverage 
remains low, partly due to a lack of awareness among health care providers, according 
to small qualitative studies by the Aurum Institute, a South African Health Research 
Organization (2010). The country’s recent large-scale IPT trial among gold miners failed 
to prove that community-wide IPT worked better than the recommended targeted 
provision to high risk groups, but did demonstrate IPT’s protective benefits against 
active TB. 
All people living with HIV should be regularly screened for TB using simple clinical 
algorithms wherever they received care. The clinical algorithm to screen adults (see 
figure 1), include four symptoms: current cough, fever, weight loss, or night sweats. The 
absence of all these symptoms can identify people living with HIV with a very low 
probability of having active TB disease (Sculier & Getahum, 2011). 
Chest radiography can be done if available, but is not required to classify patients into 
TB and non-TB groups. Contradictions include: active hepatitis (acute or chronic), 
regular and heavy alcohol consumption, and symptoms of peripheral neuropathy (DoH, 
2010:4). 
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The diagnosis of TB refers to the recognition of an active TB case, that is, a client with 
symptomatic disease due to Mycobacterium tuberculosis (DoH, 2009: 27). In the 
algorithm below, it shows the flow chart of an HIV positive client at first presentation at 
the health care facility for the screening of TB and the identification of eligible clients for 
initiation of IPT. 
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Figure 1. Algorithm for TB screening in adults and adolescents with HIV 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IPT should be part of the package of care delivered by HIV and TB service providers for  
 
 
ADULTS AND ADOLESCENTS LIVING WITH HIV 
SCREEN FOR TB WITH ANY ONE OF THE FOLLOWING 
SYMPTOMS:  
Current cough for more than 2 weeks 
Fever for more than 2 weeks 
Weight loss and night sweats 
 
Assess for contraindications to IPT INVESTIGATE TB 
NO YES 
GIVE IPT DEFER IPT 
OTHER DIAGNOSIS NOT TB TB 
GIVE 
APPROPRIATE 
TREATMENT 
AND CONSIDER 
IPT 
FOLLOW UP 
AND CONSIDER 
IPT 
TREAT FOR TB 
SCREEN FOR TB REGULARLY AT EACH ENCOUNTER WITH A HEALTH CARE WORKER OR VISIT TO A HEALTH 
FACILITY 
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 Isoniazid Preventive Therapy should be part of the package of care delivered by HIV 
and TB service provided for people living with HIV and their families. It is also one of the 
key interventions recommended by WHO in 1998 to reduce the burden of TB in people 
living with HIV, yet implementation of IPT has been very slow. Only 25 000 people living 
with HIV worldwide were reported to have received it in 2005 (WHO, 2010:35).  
  
2.3 Health information system related to IPT programme 
The monitoring and evaluation of collaborative TB/HIV activities in which the provision 
of IPT is one critical component is important to provide the means to assess the quality, 
effectiveness and coverage of services. Not many resource-constrained countries have 
an established system to monitor and evaluate the implementation of collaborative 
TB/HIV activities including the provision of IPT. Furthermore, reporting requirements 
from donor agencies that are not harmonized with internationally and nationally agreed 
indicators and process place unnecessary burden on programs (Getahum et al 2010).. 
2.4 Client monitoring and awareness programme 
Client monitoring and education can reduce the risk of serious INH related toxicity. 
Clients should be warned about symptoms of INH toxicity (abdominal pain, nausea and 
jaundice) and told to stop taking INH and return for evaluation if these occurs. They 
should also be warned on alcohol consumption while on IPT. Monitoring of for 
symptoms is very effective, but may not be practical in all settings. People living with 
HIV and receiving IPT should have regular clinical follow ups for clinical assessment 
(Getahum et al, 2010). 
2.5 Benefits of Isoniazid Preventive Therapy 
Isoniazid preventive therapy in the context of HIV is an intervention that can saves lives. 
Isoniazid Preventive Therapy for tuberculosis consists of taking one pill daily for 6-9 
months to prevent the development of active TB. Isoniazid preventive therapy has been 
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proven to be safe and effective at reducing the risk of active TB in people living with 
HIV.  
Multiple studies around the globe confirm the beneficial potential of IPT for HIV positive 
people. These studies indicated that IPT typically reduces the risk of TB disease by 
between 33% and 62% in people living with HIV. Research again suggests that the 
benefits of IPT for HIV infected people last for up to 48 months. IPT is also associated 
with a reduction in mortality (Braun, 2008). 
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2.6 THEORETICAL FRAMEWORK 
 
Figure 2. Self-developed Conceptual framework based on Ajzen’s (1988) theory of 
planned behavior 
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This study was guided by the theory of Planned Behavior (TPB) of Ajzen developed in 
1988. The theory proposes a model which can measure how human actions are guided. 
It predicts the occurrence of a particular behavior, provided that behavior is intentional 
(Fishbein & Ajzen, 1975). This theory states that, intention to perform a behavior is the 
central component in determining the behavior. Intent is influenced by attitudes, 
subjective norms and perceived control (Kerr, Weitkunat  & Morreti, 2005).  
Adhering to the prophylactic treatment of isoniazid for HIV positive clients is the 
behavior. The decision the client has to take to comply with prophylactic treatment is the 
intention. In terms of the TPB model, intention is influenced by the client’s attitude to 
complete the treatment as well as the extent to which his supporters, family and health 
care workers wishes him to finish the course of treatment. In order to ascertain attitudes 
towards behavior there is also  need to measure people’s subjective norms or their 
beliefs about how people they care about will view the behavior in question (Fishbein & 
Ajzen, 1975).  The intention to take treatment is influenced by perceived control. This 
depends on factors such as poor patient understanding of treatment; availability of 
drugs; socio economic factors; poverty; inadequate support from family and employer; 
and morbidity. 
2.7 HIV and TB 
The Human Immunodeficiency Virus (HIV) epidemic has triggered an increase in the 
number of TB cases globally (WHO, 2012a). HIV infection and tuberculosis are common 
and often co-occurring conditions, forming a lethal combination, each speeding the 
other’s progress, with a resultant increase in mortality (WHO, 2012a). 
TB is a significant re-emerging infectious disease in many parts of the world. The World 
Health Organization (WHO) global TB control report found that, in Africa, TB incidence 
rates have tripled since 1990, especially in those countries with high HIV prevalence. 
The TB incidence rates are still rising at a rate of 3–4% annually (WHO, 2005), despite 
an overall stabilization of incidence rates in many other regions. The major reason for 
this increase in rates is the co-existing HIV and TB epidemic that is affecting much of 
sub-Saharan Africa. 
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Human Immunodeficiency Virus associated tuberculosis remains a major global public 
health challenge. Globally, an estimated 33 million persons are infected with Human 
Immunodeficiency Virus and 2.2 billion persons are infected with Mycobacterium 
Tuberculosis (WHO, 2009; Getahun, 2009). By the end of 2009, an estimated 33.3 
million people were living with HIV with the vast majority in Sub- Saharan Africa and 
Asia. An estimated 2.6 million individuals had become newly infected with HIV and 1.8 
million had died of AIDS in that year alone (Padmapriyadarsini, Narendran and 
Swaminathan, 2011). Almost 300,000 people were co-infected with HIV and TB in 2010. 
South Africa is estimated to account for about 24 percent of the world’s HIV-TB burden, 
according to the WHO (2012).  
TB may occur at any stage of the HIV infections and is frequently the first recognised 
presentation of an underlying HIV infection. As compared to people without HIV, people 
living with HIV have a twenty-fold higher risk of developing TB and the risk continues to 
increase as CD4 counts progressively decline (Padmapriyadarsini, Narendran and 
Swaminathan, 2011). 
The World Health Organization had proposed a framework of TB/HIV/AIDS 
collaborative activities to prevent the occurrence of TB-HIV disease. IPT, intensified TB 
case finding, and infection prevention are the major strategies to control TB in HIV-
positive individuals (WHO, 2005). The World Health Organization recommends 12 
collaborative HIV/TB activities, including the “Three I’s for HIV/TB” (isoniazid preventive 
treatment, intensified case finding, and infection control for TB). This should be seen as 
core prevention, care, and treatment services for HIV infection. Of the 12 activities, 
there has been progress in implementing testing for HIV infection, providing 
trimethoprim-sulfamethoxazole preventive therapy, and antiretroviral therapy (ART) 
(WHO, 2009). 
The DOTS strategy on its own is inadequate for the optimal management of co-infected 
patients. The TB-specific Millennium Development Goals of reducing the prevalence 
and death rates of TB by 50% by 2015 will not be achieved in the high HIV-burden 
areas unless additional strategies and interventions are put in place. Under the 
27 
 
leadership of the World Health Organization (WHO) and the Stop TB Partnership, TB-
HIV guidelines (WHO, 2002), a TB-HIV strategic framework (WHO, 2003) and an 
interim TB-HIV policy (Table 1) (WHO, 2004) have all been developed to reduce the 
burden of TB-HIV disease in severely affected countries. One of the main prongs of the 
TB-HIV interim policy is to reduce the impact of HIV in co-infected patients. This review 
will focus on three important interventions: provider-initiated HIV testing and counseling, 
cotrimoxazole preventive treatment (CPT) and antiretroviral treatment (ART). 
2.8. Implementation of Isoniazid Preventive Therapy 
The current recommended dose of IPT for adults is 300 mg of isoniazid per day with 
Pyridoxine 25 mg per day for six months, with 36 months conditionally recommended in 
areas of high TB prevalence and transmission as well as those with positive TST test 
(montoux test) (ART guidelines, 2013). 
Many TB program officials and health care providers fear that IPT programmes will 
inadvertently lead to the development and worldwide spread of multidrug-resistant TB 
(MDR-TB) and extensively drug-resistant TB (XDR-TB). Close monitoring of IPT 
program participants can alleviate this fear, as strong evidence exists that IPT does not 
increase the risk of developing isoniazid-resistant TB in the absence of active TB. To 
prevent individuals with active TB from receiving IPT, ruling out active disease at the 
beginning is most important. If an individual develops new symptoms of TB during IPT 
treatment, IPT should be stopped and a diagnosis of TB should be confirmed or ruled 
out. 
Tuberculosis screening should be performed at the time of initial presentation to HIV 
care and thereafter at every visit to a health facility or contact with a healthcare worker. 
Screening for TB is important regardless of whether patients have received IPT or ART. 
Isoniazid Preventive Therapy is primarily an HIV intervention and is part of high-quality 
services for people living with HIV (Sculier & Getahum, 2011). 
In most settings provision of IPT to people living with HIV should be under the 
responsibility of national HIV programmes and HIV services providers. IPT should also 
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be part of a TB prevention  package  along with infection control for TB, intensified 
case-finding and provision of early ART to people living with HIV with CD4 count <350 
cells/mm3 (Sculier & Getahum, 2011). 
Successful examples of IPT implementation highlight its feasibility in diverse settings. 
The WHO Guidelines for Intensified Tuberculosis Case-Finding and Isoniazid 
Preventive Therapy for People Living with HIV in Resource-Constrained Settings 
provide in-depth information on the evidence base for IPT. The target audience for 
these guidelines includes health care workers, policy makers, health program 
managers, governments, nongovernmental organizations, funders and patient support 
groups. The International Training and Education Center for Health (I-TECH) website 
also provides general information on the first steps for implementation of an IPT 
program (DoH, 2010:14). 
2.9. Additive Adverse Effects of IPT programme 
Adverse reaction to drugs are common among patients with HIV related TB, especially if 
taking HAART concomitantly. Rash, fever, hepatitis and peripheral neuropathy are 
common side effects of anti- TB drugs especially INH. Isoniazid drug may cause 
overlapping toxicity (Table 2). Majority of side effects occurs within the first two months 
of starting treatment. Additive drug toxicity compromises patient safety and is an 
important cause of discontinuation and interruptions of IPT (British HIV Association, 
2014). The table below indicated the adverse reactions common among HIV positive 
client on ART and on IPT. 
Table 2. Additive adverse effects 
Adverse reaction Main ARV 
drug involved 
Main 
anti-tuberculosis 
drug involved 
Peripheral neuropathy 
(early or late side effect) 
Stavudine Isoniazid Cycloserine 
Hepatitis (usually an early Nevirapine Rifampicin, Isoniazid, 
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side effect. This is a major 
problem when combining 
rifampicin and second-line 
ritonavir-boosted protease 
inhibitor regimens) 
Pyrazinamide 
Gastrointestinal 
dysfunction, e.g., diarrhea, 
abdominal pain (early or 
late side effect) 
 
 
ALL 
 
 
ALL 
Skin rash (usually early 
side effect) 
Nevirapine Rifampicin, Isoniazid, 
Pyrazinamide, Cycloserine 
Central nervous system 
dysfunction (early or late 
side effect) 
Efavirenz Isoniazid Cycloserine 
 
2.10. Factors contributing to treatment default 
 
HIV infected patients have been reported to have twice the risk of defaulting when put 
on treatment compared to HIV negative patient as they deal with many medications. 
Similarly, poorer TB treatment success rate for HIV positive patients among re-
treatment patients has previously been reported in Nairobi (Chakaya, 2002:545).  
Many patients in the study were infected with HIV. The infected patients often attend 
separate clinics or facilities for other conditions and HIV care services, thus increasing 
transport and other opportunity costs. This may lead to patients defaulting in their 
treatment. Similarly, an Indian study (Jaggarajamma, Sudha, Chandrasekaran, Nirupa, 
Thomas & Santha, 2007) documented that a higher rate of migration from a treatment 
center was observed among patients who defaulted. They discovered that the relocation 
was based mainly on occupational grounds. 
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Another factor implicated with defaulting among patients is the problem of side effects. 
The side-effects profile of anti-TB drugs is magnified in patients with concurrent HIV 
treatment (Fry, Khoshnood, Vdovichenko, Granskaya, Sazhin, Shpakovskaya, 2005). It 
is possible that minor adverse effects, which did not pose a danger in the clinician’s 
view, nevertheless resulted in discomfort and contributed to a patients’ decision not to 
continue treatment (Philip, LoBue, Kathleen, Moser, 2003). Combining antiretroviral and 
anti-TB drug such as INH means taking many pills daily. This can be difficult and 
challenging to most patients. That patients with HIV comorbidity are significantly more 
likely to default is sufficient evidence that HIV and TB care should be integrated. 
In addition, (Soriano, 2002) in a qualitative study in Mutia, Zamboanga del Norte 
likewise stressed that most of those who defaulted did so because of an inability to deal 
with the drug’s adverse effects. She further stressed that defaulters perceived that the 
health benefits of undergoing treatment were not worth suffering the negative side 
effects of the medicine. That long term goals of cure and recovery were disregarded by 
defaulters for the immediate goal of seeking relief from the discomfort brought about by 
the side effects of medication. 
Ignorance by patients has been cited as a factor contributing to defaulting. There are 
different reasons for non-adherence to medications such as forgetfulness, being busy 
and away from home was reported. This is in keeping with the findings of other studies 
(Mc Callum, 2007; Meichenbaum & Turk, 2006). Patients’ who complied with their clinic 
appointments were more likely to complete their regimen. This is consistent to a similar 
study elsewhere (Rennie, Bothamley, Engova, Bates, 2007).  
Dunbar (2004) examined the contribution of heath service factors to non-adherence to 
treatment. According to a study conducted in Kenya and Zambia, the poor quality of 
physicians’ interpersonal skills has been shown to negatively affect adherence (Dunbar, 
2004; Bartlett, 2006). Four cross-sectional studies showed the impact of poor patient-
physician relation on adherence in different setting (Sbarbaro, 2006; Clark, 2000, 2004; 
Stewart, 2006). Randomized trials also showed that an increase in non-adherence in 
situations where doctors appear insensitive, use medical jargon, view patients as 
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complainers, or do not provide clear messages about the cause of the illness or reasons 
for treatment (Mead & Bower, 2002; Korsch & Negrete, 2003). 
Also, according to (Guillaume-Signoret, 2006) and (Uwah, 2006b) inadequate 
counseling and information provision by health personnel resulted in TB treatment 
default. In addition (Selig et al., 2003:587) recognized that the negative attitude of 
healthcare professionals toward TB patients correlated with non-adherence with 
treatment. 
Stigma or feeling uncomfortable to take the drug in front of others was one of the factors 
for non-adherence to IPT. A stigma attached to TB in China leads to imposition of socio-
physical distance and participatory restrictions on those suffering from the disease (Xu. 
2009). In Ghana, (Dodor, 2004:1335) found that patients appeared to be ashamed of 
their condition. This finding confirmed the findings of Johansson (1996) that patients did 
not disclose their TB status from family members and friends to avoid social isolation 
and to protect their dignity. In addition, (Rennie, Bothamley, Engova, Bates, 2007:731) 
and (Munseri et al., 2008:1040) found low adherence to preventive INH treatment 
because of the fear of stigma. 
Lack of effective social support networks and unstable living circumstances are 
additional factors that create an unfavorable environment for adherence to treatment 
(WHO, 2003). Social and family support positively influenced adherence among patients 
(Rowe et al., 2005:266). 
2.11 Conclusion 
This chapter has reviewed literature under the following subheadings: theoretical 
framework, HIV and TB, ITP, ITP implementation and factors contributing to non-
compliance. The following chapter covers the research methodology that was followed 
in this study. 
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CHAPTER 3 
METHODOLOGY 
 
3.1 Introduction 
This chapter outlines the research methodology applied during this study. It included 
discussion of the research design, research setting, the study population, the target 
population, the sampling procedure , the pilot study,  data collection methods,  data 
analysis, the trustworthiness of the study and the dissemination and implementation of 
results. 
3.2 Research Design 
In this study the researcher focused on the qualitative approach which is descriptive, 
explorative and contextual in nature using the phenomenological design. 
 According to (Corbin and Strauss, 2008, 12) qualitative research allows researchers to 
probe into the inner experiences of participants to determine how meaning is formed 
through culture, and to discover rather than to test variables. In this study the qualitative 
approach offered the participants an opportunity to express their views on Isoniazid 
Preventive Therapy program. The participants were allowed to express themselves in a 
manner that revealed their real situation. The participants were encouraged to describe 
their world in their own terms. 
This study intended to examine human experiences. The choice of the 
phenomenological design as (Brink, 2006: 113) states examines human experiences 
through the descriptions that are provided by the people involved. The experiences are 
called “lived experiences”. The purpose of the phenomenological research, then, is to 
describe what people experience in regard to certain phenomena, as well as how they 
interpret the experiences or what meaning the experiences hold for them. Therefore 
phenomenology is an approach that concentrates on a subject’s experience rather than 
on the person as a subject or object. In this study the inner experiences of the 
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participants revealed exactly what happened to them while they were on treatment and 
explained, describing in depth the reason for stopping the treatment, as the researcher 
explored and discovered the similarities between the participant’s experiences. 
3.3 Research Setting 
The study was conducted at the Bhisho Primary Health Care Services in the King 
Williams Town area. This is a small town in the Eastern Cape Province in South Africa. 
It is situated along the banks of the Buffalo River and forms part of the Buffalo City 
Municipality Metropolitan Municipality.  
King, as the town is locally called, stands 389 meters above the sea at the foot of the 
Amatole Mountains and in the midst of a thickly populated agricultural district. It has a 
population of nearly 100 000 inhabitants, surrounded by townships and villages. King 
has 2 tertiary health care institutions, 2 community health care centers and 27 primary 
health care facilities under it, of which 4 of the primary health care facilities were used in 
the study. 
3.4 Study Population 
The study population for the study was all HIV positive clients defaulting IPT at the 
Bhisho Primary Health Care Services in King William’s Town. 
3.5 Target Population 
Target population for this study was all HIV positive clients defaulting IPT at Tyutyu, 
Ginsberg, Bhisho Gateway and Sweetwater clinics. 
3.6 Sampling 
The researcher focused on a non-probability sampling using a purposive method. The 
researcher used the client records available at the clinic and visited the clients that 
defaulted in the IPT program as the sample. The intention of the researcher was to 
interview at least 15 clients although data saturation was reached at 14 clients. 
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3.6.1 Inclusion Criteria 
Inclusion sampling criteria are those characteristics that a subject or element must pose 
to be part of the target population (Burns and Grove, 2009: 343). Inclusion criteria for 
this study embraced HIV positive clients, males and females between the ages of 18 
and 40 years with a negative smear TB sputum defaulting IPT. They were mentally 
stable and willing to participate. 
Brink (2009:124) states that it is critical that the researcher carefully defines and 
describes the population, and also stipulates criteria for inclusion. These criteria are 
referred to as eligibility criteria, inclusion criteria or distinguishing descriptors. 
Researchers use them as the basis for their decision of whether an individual or object 
would or would not be classified as members of the population in question. 
3.6.2 Exclusion Criteria 
Exclusion sampling criteria are those characteristics that can cause a person or element 
to be excluded from the target population (Burns and Grove, 2009:343). In the study the 
researcher excluded the HIV positive clients with positive smear TB sputums, children, 
those with psychiatric diseases and HIV positive with dementia. 
3.7 Pilot Study 
A pilot study was conducted at the Breidbach clinic to clients that were not included in 
the main study. This was done by taking HIV positive clients who were on IPT. The 
number of participants involved in the study was 6. They were interviewed using the 
interview guide. Probing questions were guided by the client’s responses. Pilot study 
was conducted to assist the researcher to master interviewing skills and to check the 
relevance and the effectiveness of the interview guide.  
3.8 Data Collection 
In order to collect data, the researcher should be able to access the data that needs to 
be collected for the study. Data can be gathered from a number of sources including 
written documents, records, workplace, the internet, surveys or interviews. 
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The method of data collection for this study was in-depth unstructured face to face 
interviews. In-depth interviews allow the participants to describe their lived experiences 
and the meaning of events taking place in their lives. An interview guide was used to 
conduct the interview. The participants were asked questions, for an example: 
 What are your lived experiences regarding IPT? 
 What do you think can be done to change the situation? 
Other probing questions depended upon the answers of the participants. 
An audio tape-recorder was used to obtain the information from the participants and a 
notebook pad was used for field notes. Data was transcribed verbatim from the audio 
tape. A good working relationship with the participants was developed. Trust and 
rapport was attained by using sound communication skills, empathy and genuine 
acceptance. 
3.9 Data Analysis 
Brink (2009: 70) maintains that data analysis entails categorizing, ordering, 
manipulating, summarizing the data and describing them in meaningful terms. 
After each interview with a participant data was analyzed by listening to the tapes again 
and again to gain full understanding of what the participant was saying. This was done 
by noting down important points such as pauses of the client, highs and low, when 
she/he sighed. This attributed meaning and assisted the researcher to interpret what the 
phenomena meant. During this process themes were generated. 
Whilst transcribing the recorded interviews the researcher made reflective notes and 
marginal remarks to highlight the important aspects of the interview. The next step was 
the coding. This is classification of words or phrases or descriptive words or categories 
to form a story. 
36 
 
3.10 Trustworthiness 
To address the matter of accuracy and appropriateness of data, the researcher used 
conformability by going back to the participants with the data and findings as a means 
of checking the trustworthiness of the data. This afforded an opportunity to ascertain 
factual accuracy and also confirmed or disconfirmed the researchers’ understanding by 
the participants. 
To ensure credibility, each person who was approached was given an opportunity to 
refuse to participate in the study. This ensured that the data collection sessions involved 
only those who were genuinely willing to take part and were prepared to offer data 
freely. Participants were encouraged to be frank from the outset of each session, with 
the researcher aiming to establish a rapport in the opening moments (Shenton, 
2004:66).  
This study safeguarded dependability by ensuring that the process within the study 
was reported in detail, thereby enabling a future researcher to repeat the work and to 
obtain similar results. The research design may be viewed as a “prototype model” so as 
to enable readers of the research report to develop a thorough understanding of the 
methods and their effectiveness (Shenton, 2004:66). 
To ensure transferability the researcher used purposive sampling with a dense 
description of the research methodology, setting the context of research and literature 
control. This would enable future researchers to get the similar findings of a study in 
similar situations. The researcher provided the information that potential appliers 
needed to make a decision on transferability (Spaziale & Carpenter, 2011). 
Transferability refers to the ability to apply the findings in other context or to other 
participants (Brink, 2012:173). It is also called “fittingness” which refers to the probability 
that the findings have the same meaning to others in similar situations (Speziale & 
Carpenter, 2011:97). 
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3.11 Ethical Considerations 
The researcher in this study ensured that ethics were considered, that the rights of the 
subjects are not infringed. Informed consent forms were obtained before the research 
began. Formal ethical clearance from the University of Fort Hare Ethical Committee and 
approval from the Department of Health was obtained. It was ensured that no research 
processes infringed on the human rights or revealed the confidential nature of the 
individual participation (Wisker, 2008:86). 
Wisker also mentions that ethical guidelines insist that researchers should not do 
physical or psychological harm and that, where human subjects are involved, the 
participants should give their fully informed consent before taking part. Even though 
participants gave consent initially they should be able to withdraw at any time and to 
deny the use of their information in the research (Wisker, 2008:87). That is why the 
participants were given an information sheet with all the information such as the 
purpose of the study, procedures, risks involved, benefits of the study to the participants 
and their rights to withdraw, at any time, from the study. The information sheet, consent 
forms were available in English, Xhosa and in Afrikaans. As the participants are HIV 
positive on IPT and knowing that HIV/AIDS is a sensitive topic, the interviews were 
conducted in privacy. Counseling support was available for the participant as the 
researcher is a professional nurse trained in counseling.  
3.12 Dissemination and Implementation of Results 
After the report has been completed it was submitted to the University of Fort Hare 
Nursing Science Department and then to the University’s library. The results will then be 
sent to the Department of Health’s Research Office and to the Management of the 
Buffalo Metropolitan Municipality. 
Research articles from the study will be published in accredited nursing journals 
nationally and internationally.  Research papers and posters will be presented in 
conferences and symposia. 
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3.13 Conclusion 
The (DoH, 2010: 12) puts it clearly that information about TB Preventive therapy should 
be made available to all people living with HIV/AIDS. Experiences from trials and 
operational research have stressed the importance of relevant information for the 
patients including the issue of adherence. Tuberculosis preventive therapy must be 
discussed and adequately planned to ensure full understanding and adherence by the 
patient. During post-test counseling following a diagnosis of HIV, the patient should be 
informed about the benefits of the TB preventive therapy, and should be invited to return 
to the clinic for the service. 
If all this is done patients will be able to trust and have confidence in the health system, 
therefore making a difference in the global target to halt TB. The methodology of the 
study thus helped the researcher to unfold the views of others in an organized manner 
and in this case described the experiences of the HIV positive clients on IPT. 
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CHAPTER 4 
DATA PRESENTATION AND ANALYSIS 
4.1 Introduction 
 
This chapter describes the results from respondents on their experiences as HIV 
positive clients defaulting IPT services. The concern of the researcher was that these 
clients are likely to develop TB and when they have developed TB they will develop 
resistance to TB drugs containing isoniazid. This also leads to multi drug resistance 
(MDR) or extensively drug resistance (XDR) TB. This chapter will look at the reasons for 
defaulting and recommend possible strategies that can be used to prevent isoniazid 
default.    
4.2 Demographic Information 
This section focuses on the demographic information of the participants. This study had 
a total of fourteen participants, males and females. Each participant signed a consent 
form before the interview and the purpose of the study was explained.  
4.2.1 Age distribution of participants 
Table 3.  Age distribution 
Less than 20 20- 29 years 30- 39 years 40- 49 years TOTAL 
1 4 8 1 14 
 
4.2.2 Gender distribution of participants 
Table 4: Gender distribution 
Male Participants Female Participants TOTAL 
4 10 14 
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. 
4.2.3 Clinics used by participants 
Table 5: Clinic use 
CLINIC Tyutyu Bhisho Gateway Ginsberg Sweetwaters TOTAL 
Number of 
participants 
attended 
 
7 
 
3 
 
3 
 
1 
 
14 
 
4.2.4 First diagnosis of participants with HIV 
Table 5:  When were participants diagnosed with HIV 
Year of diagnosis 2000- 2005 2006- 2010 2011- 2014 
No. of participants 
diagnosed 
 
1 
 
1 
 
12 
 
4.2.5 Duration on IPT 
Ten (10) participants had been on IPT for a month or two. The remaining four 
participants had been on IPT for three months. 
4.3 Qualitative Data Analysis of Participant’s Responses 
This section covers the results from the responses of participants in responding to the 
objectives of the study in exploring and describing the experiences of the HIV positive 
clients defaulting IPT so as to determine possible strategies that can be used to prevent 
isoniazid (INH) default. There are four main themes that emerged from the data 
analysis: (1). Reasons for not taking treatment, (2). Quality of services, (3).Knowledge 
of treatment, (4). Participant’s suggestions in improving of health services. 
The themes were further classified into sub- themes as indicated in the table below: 
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Table 7: Themes and sub- themes regarding the experiences of HIV positive on 
IPT programme. 
Number Themes Categories Sub- themes 
1. Reasons for not taking 
treatment 
Work related issues 
 
Overlooked their 
return dates 
 
Nurses did not tell 
them that they can 
get medication in 
cities they visited 
 
They stopped 
medication/ 
defaulted 
 
Afraid of going back 
to the clinic 
Fearing the 
attitudes of nurses 
Afraid of being 
scolded 
  Family related issues 
 
Had infants to take 
care for 
  Side effects 
 
Experienced pain in 
the legs and hands. 
 
Experienced cold 
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feet and was told 
by nurses to stop 
medication. 
  Ignorance of patients 
 
Stopped 
medication. 
 
Stopped medication 
without consulting 
health providers. 
  Negligence of nurses 
 
Nurses did not 
speak to the patient 
who was defaulting. 
 
Nurses just looked 
at the paper and 
patient left without 
proper medication. 
 
An HIV positive 
patient who was 
diagnosed for the 
first time, treatment 
to prevent TB was 
given without any 
explanation. 
 
Nurses gave 
medication the first 
month but did not 
give medication in 
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the 2nd month 
 
  Denial of HIV status 
 
Found it difficult to 
come to the clinic. 
Was not ready to 
disclose. 
Have not come to 
terms with her 
condition. 
 
  Stigmatization 
 
Afraid to be seen at 
the clinic. 
Going to the clinic 
will expose her 
status. 
  Lack of privacy 
 
No consulting 
rooms. 
People are able to 
see which 
medication is given 
to other clients 
 
2. Quality of services 
provided 
 Lack of support from the 
health services. 
 
Poor service 
rendered. 
 No support given. 
 
Fear of nurses. 
 
No detailed 
information is given 
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to the client 
regarding going on 
holiday. 
 
Nurses are 
disrespectful. 
 
Fear to go to clinic 
when defaulted. 
 
No home visits 
done. 
No follow ups done. 
  Poor understanding of 
policies and guidelines by 
nurses. 
 
Patients 
complained of side 
effects of 
medication. 
 
Nurses unable to 
explain the duration 
of medication. 
 
 
3. Client knowledge about 
treatment. 
Lack of knowledge about 
treatment  
 
Lack of information 
from professionals 
regarding 
medication and 
side effects. 
4. Suggestions by 
participants 
Change of nurses 
attitude. 
Nurses and care 
givers to change 
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Improved means of 
communication. 
 
Maintenance of privacy. 
Clear consultation times. 
 
 
Clear guidelines for 
clients. 
 
their attitudes. 
 
The use of text 
messages. 
 
Privacy. 
Proper consulting 
times. 
 
Plan from 
government. 
 
Patients to be given 
information. 
 
 
4.3.1 Reasons for not taking medication 
The results from the data revealed that the reasons for not taking medication were work 
and family related issues, side effects, patient ignorance, negligence of nurses, and 
denial of HIV status, lack of privacy and fear of stigmatization. 
4.3.1.1 Work related issues 
 Four participants identified work related issues as their reasons for not taking 
medication. Two participants overlooked their return dates because they went away for 
work purposes and the nurses did not tell them that they can get medication in cities 
they visited. They stopped taking medication and when they got back they were afraid 
of going back to the clinic. They claimed fearing the attitudes of nurses as they will most 
probably scold them. Below are some responses relating to this: 
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“Yes, I was in Cape Town I did not know that I could go to the clinic and get my 
treatment. I thought I should come to this one where I reside. I was never told by 
the nurses that I can obtain them from any other clinic.” 
 
“They said I should go back to them then they gave me the return date of the 13th. 
I was doing some business, no catering in Graham’s town.” 
 
4.3.1.2 Family related issues. 
Two other participants could not go to the clinic as they had infants to care for and they 
missed the date of return. Also, just like the other participants they were afraid of being 
shouted at by nurses. 
“Hallo sister my problem is I have a child I could not come because my child was 
not feeling well. I was afraid to come to the clinic the following morning because I 
missed the date. I was afraid of nurses. They have bad attitude and they shout. 
They shouted at me before when I missed my date.”  
4.3.1.3 Side effects 
 Three participants stopped taking their medication as they were experiencing side 
effects to the medication. They experienced pain in their legs and hands. One was 
experiencing cold feet and was told by the nurses to stop her medication. The other two 
stopped after they fell ill even though they were told by nurses it will pass with time. The 
following extracts were expressed by participants who experienced side effects: 
“I was given a brown tin with a white lid. I used it for the first time and the third 
time until I finished it. I tolerated it but I came to the clinic and reported that it 
made my feet to be cold. I had to soak my feet in hot water every night before 
going to bed. I did that until the pills were finished. When they were finished I 
reported here at the clinic and I was told to stop them.” 
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“The reason is I stopped taking the pills because I noticed that my hands and feet 
became painful. I went to the clinic and reported nothing was done about that. So 
I decided to stop taking them.”  
“I used treatment for two months but I experienced painful legs I continued with 
my treatment then I came to the clinic and reported this. I was told that it will go 
away on its own. I had that hope. Then I never came for the third one because I 
did not see the point of taking this treatment because my legs were no longer 
painful. “ 
4.3.1.4 Ignorance of clients 
One of the participants stopped taking the medication due to her ignorance of the 
importance of the medication. She was taking both medication for IPT and the PMTC 
prophylaxis for protecting the baby against HIV infection. After the prophylaxis 
medication was completed she decided to stop both of them without consulting health 
provider. Therefore, it was negligence on the part of the patient. 
“The reason is that I only came for the one pill and when it was stopped I decided 
to stop both pills.” 
4.3.1.5 Negligence of nurses 
On the other hand there was also negligence by nurses which caused patients to 
default their medication. One participant was given medication the first months and 
when she came again the nurses did not give her any medication. The nurses in the 
clinic did not speak to her. They just looked at a paper and she left without proper 
medication. This was the reason for her stopping medication. Another participant tested 
HIV positive for the first time. He was given medication for a month for preventing TB 
without explanations for taking the medication and the duration of the treatment. He was 
told to come back after 6 months for a CD4 count. When he returned they did not 
mention any TB medication. The same applies for other participants. Below are some 
responses relating to this: 
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“I can say it was not my fault. I came for my first visit and I was given INH and I 
was told that I am going to take it for six months. OH but the following month 
when I came I was not given the treatment and I do not know why. I was attended 
by a coloured lady the first time and then on another visit by a dark lady and I 
never asked. I took INH for two months and I was never given for the third time.” 
“The time I came here I came to test for HIV. I was never told about those pills 
because I was shocked. I was given pills and told that they prevent TB. I was 
never to come again and I was also shocked. I took those and never came back. I 
was told to come back after six months for CD4 count. I came back and did CD4 
count then I left. I came back for results. Still nobody talked about the INH or 
asked about whether I am taking INH or not.”  
4.3.1.6 Denial of HIV status 
The other reason that prompted a participant to stop treatment was because he was still 
in denial about his HIV status. The participant found it difficult to come to the clinic as he  
was not ready to disclose his status as he have not come to terms with his HIV status 
with regards to understanding and acceptance.  
“No sister it is difficult to come because there ladies and this clinic are in front of 
the houses. So it is not easy for me to come to the clinic. It is one of the reasons. 
I have not really accepted my status. I am trying to come to terms with it and it 
stresses me out. These people make it difficult for me. It is only me and my 
girlfriend who know about this. I have not told my family about this. That is why I 
am afraid to come to the clinic. Coming to the clinic is going to expose me. They 
will gossip and there is someone I am eyeing. I am not ready.”   
4.3.1.7 Stigmatization 
Participants are afraid to be seen frequently at the clinic as this will be associated with 
taking of ARV’S. One participant mentions that going to the clinic will expose his HIV 
status and this becomes a problem. Below are some responses relating to this: 
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“No sister it is difficult to come because there ladies and this clinic are in front of 
the houses. So it is not easy for me to come to the clinic………… Coming to the 
clinic is going to expose me.” 
 “The reason why I don’t come for treatment is because when you go and collect 
your treatments there are people around.”  
4.3.1.8 Lack of privacy 
 
The fact that the nurses do not used consulting rooms when giving medication to the 
clients made the participants feel that there is no privacy and other people attending the 
clinic are able to see which medication are they given 
“The reason why I don’t come for treatment is because when you go and collect 
your treatments there are people around. The nurses cannot give you in a private 
place. They give you in front of everyone.” 
4.3.2 Quality of services provided 
 
This section focuses on the quality of the services provided by the health providers. 
According to all participants they had received poor services in terms of not receiving 
support, information on reporting when going away or sending someone to obtain their 
medication if they are unable to do so. Participants also had problems with disrespectful 
nurses as they scolded the patients. When a patient missed a return date they feared 
returning to the clinic as they are shouted at. This set of circumstances prompted them 
to stop taking the medication. 
 
4.3.2.1 Lack of support from the health service 
 Participants had never had a visit from the community service workers to enquire why 
they stopped taking medication. They have never visited them or made follow-ups. 
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“No one visited.” 
 “Thought caregivers would come and visit and enquire about why I haven’t been 
to the clinic. They are supposed to come and check how treatment is going.” 
 The participants claimed to have feared the attitudes of the nurses as they will most 
probably be scold and shouted at. This again indicated the role played by the nurses in 
increasing the default rate of IPT. Below are the responses of the participants with 
regard to this: 
 
“I was afraid of nurses. They have bad attitude and they shout. They shouted at 
me before when I missed my date.”  
“I thought of being shouted at because nurses are known for that.” 
“They shout, ask you many questions and then you feel ashamed because you 
did not come to fetch the treatment.” 
 
4.3.2.2 Poor understanding of policies and guidelines by nurses 
 Participants were given medication without an explanation of the duration and what it is 
used for. Participants who had experienced pain in their hands and feet were not given 
the white pills (pyridoxine) which alleviate the pain. Another participant was taking one 
white and one yellow pill. When she got ill with cold feet the nurses just told her it will 
pass without explaining that she can take up to 4 white pills for the pain. This clearly 
indicates that the policy and guidelines on IPT are not understood. Below are some 
responses relating to this: 
“No, they gave me and told me to come after six months, I do not know how long 
the treatment will take or what the treatment was for, I had only being diagnosed 
with HIV.” 
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 “I thought of being shouted at because nurses are known for that. “When you 
come to the clinic there is a paper with all your information. The nurses just ask if 
you are here for treatment and just give you treatment and not say anything.” 
“The reason is I stopped taking the pills because I noticed that my hands and feet 
became painful. I was only given the yellow ones.” 
“The reason is I stopped taking the pills because I noticed that my hands and feet 
became painful. I went to the clinic and reported nothing was done about that. So 
I decided to stop taking them.”  
Some participants had no idea how long the treatment will last and what was the 
treatment for or where to get the treatment if a client is not around the area. This shows 
that poor information sharing of nurses can cause increase in the default rate of IPT. 
“No, they gave me and told me to come after six months, I do not know how long 
the treatment will take or what the treatment was for, I had only being diagnosed 
with HIV.” 
“I got the white and yellow pills and I was not told the duration.” 
“The time I started this treatment I am not sure whether it is ARV’s but I read that 
pamphlet inside the pills it said one might experience itchiness or rash. Does this 
treatment do that or it was caused by ARV’s”  
 
“Yes, I was in Cape Town I did not know that I could go to the clinic and get my 
treatment. I thought I should come to this one where I reside. I was never told by 
the nurses that I can obtain them from any other clinic.” 
 
4.3.3 Client’s knowledge about the treatment 
Some of the participants did not know have information about the treatment. For 
example two of the participants did not know about the use of the yellow pills; another 
participant did not know the importance of taking the medication and the consequences. 
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Some participants even asked information on the perceived side effects which people 
talk about and if it is important to take the medication when you do not have the TB at 
that time. In addition, participants did not know that one can get medication wherever 
they are even if there are not in their resident area.  
4.3.3.1 Lack of knowledge of treatment 
As mentioned above that participants did not have information about the treatment they 
were given at the clinic and this contributed to the fact that they stopped taking 
treatment. 
“No sister no one talked about that. I was only told about the CD4 count.” 
 “The time I started this treatment I am not sure whether it is ARV’s but I read that 
pamphlet inside the pills it said one might experience itchiness or rash. Does this 
treatment do that or it was caused by ARV’s?”  
“I got white and yellow pills and was not told the duration.” 
 
“Yes, I was in Cape Town I did not know that I could go to the clinic and get my 
treatment. I thought I should come to this one where I reside. I was never told by 
the nurses that I can obtain them from any other clinic.” 
 
 
 
 
4.3.4 Suggestions by participants to increase knowledge and avoid defaulting by 
patients 
 
This section covers the suggestions made by participants when asked what can be 
done to improve knowledge about the treatment and for patients not to default their 
medication. Every participant made a suggestion and some were similar to each other 
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but the main one was to change the attitude of nurses as they disrespect patients. Other 
suggestions are as follow:  
 
4.3.4.1 Nurses attitude 
 Nurses and caregivers to control their attitudes and moods. To stop shouting at 
patients and be patient and understanding. 
“Point number one, nurses must lose the attitude we default because they are 
disrespectful and they shout at us. They must stop shouting because they are the 
ones that make us to default. Point number two the caregivers must also loose 
the attitude because this is their job, they must visit us so that we don’t feel 
scared to come to the clinic.”  
4.3.4.2 Use of text messages as reminders 
 Using text messages reminders so that patients will not forget their return date 
and any other information that can be sent to the patients 
“If there can be sms reminders because I used to see that on television for 
example. The sms reminders can be sent to those who just started treatment.” 
4.3.4.3 Privacy 
 Using consulting rooms when giving out medications to provide privacy 
“It would be better if we can have our special place in the clinic because others 
are very sick. Can’t we have a special room where I can go alone. Or when we are 
in the waiting room go to the consulting room so that someone who is sitting 
next to me won’t know what I came here for. Be treated like someone who has 
any other disease. The need for pills they do no react with or pills that counteract 
the side effects from the medication.” 
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“Maybe change the treatment if it can be changed and give me other pills 
together with the small white ones.” 
 
4.3.4.4 Proper consultation times 
 Nurses to spend time with patients so that they learn more about the treatment 
and they can feel free to ask if they have any questions  
“Yes they must spend time and listen to whatever we want to say on that 
particular day.” 
 
4.3.4.5 Plan on discrimination 
 Government to come with a plan to curb discrimination against HIV patients 
“People must stop discriminating us. We are discriminated against because of 
our disease. This is our disease we need to be supported and not be made a 
laughing stock. Government must come up with a plan.” 
 
4.3.4.6 To be given information 
 Patients need to be told more about the medication, its use, why it is important, 
what to do when going away, who to report to, the side effects, how to deal with 
the side effects and any other information about the medication. 
“I think first of all people need to be told about these pills so that people can be 
knowledgeable and protect themselves.”  
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4.4  Conclusion 
In summary, from the findings above it is clear that many patients are not taking their 
medication in the prescribed manner. Side effects, work and family issues, ignorance by 
patient, negligence by nurses and denial of HIV status have an impact on defaulting of 
the medication. Suggestions such as the use of text reminders, using consulting rooms 
for privacy, given information about the medication, to stop discrimination, should be 
implemented to curb the problem of defaulting by patients as it has an impact on their 
health. The success of reducing defaulting cases rest with both the patients and the 
health sector’s attitudes and dedication in dealing with HIV and TB. Failure to do so may 
lead to high morbidity rates. The following chapter will deal with the discussions of 
results and recommendations. 
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CHAPTER 5 
DISCUSSION AND RECOMMENDATIONS 
5.1 Introduction 
 
The chapter presents the research findings of the study and makes reference to 
relevant research to support the findings of the current study. In order to contextualize 
the research, comparisons are drawn with available literature on experiences of HIV 
positive clients defaulting isoniazid preventive therapy. This chapter provides 
conclusions that can be drawn from the research and offers suggestions for future 
research into factors leading to defaulting of isoniazid preventive therapy among HIV 
positive clients. 
5.2. Discussion 
 
This section focused on discussion of the results from the different themes and made 
reference to relevant research to support the findings. 
5.2.1 Demographics 
 
Defaulter rate is high among the age groups 20-29 and 30-39 of the participants. This 
finding is in line with the findings of (Ane-anyangwe, 2006b:589 and Dodor, 2004:1340) 
which indicated higher default among age groups of 21-40 and 25-44 respectively. 
In this study defaulter of TB treatment cases and controls was high among females than 
the male respondents. This finding is contrary to the findings of  
(Hill, et al, 2005:1351) that the rate of TB treatment defaulting was higher in males. 
In this study the respondents received treatment from four clinics in the Buffalo City 
Municipality area. The majority of the respondents were diagnosed between 2011 and 
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2014. Also, the study revealed that the respondents have been on IPT between one to 
three months. 
5.2.2 Reasons for not taking medication 
 
The respondents in this study identified work and family related issues as their reasons 
for not continuing with their medication. This included missing return dates because 
they went away for work purposes and also had infants to care for. This finding 
substantiates the findings of (Muture. Keraka, Kimuu, Kabiru, Ombeka and Oguya., 
2011:696) who conducted a study in Kenya which indicated that from the 150 patients 
who did not complete treatment, 15 clients attributed their default to travelling away from 
the treatment locality thus missing scheduled appointments. Similarly, a Nigerian study 
(Akande and Abdulraheem, 2005:32) showed that among the reasons given for 
defaulting was travelling away from a treatment centre, though no association was 
shown with defaulting. Similarly, an Indian study (Jaggarajamma, Sudha, 
Chandrasekaran, Nirupa, Thomas and Santha, 2007:134) documented that a higher 
rate of migration from treatment centre was observed among patients who defaulted. 
They discovered that the movement was based mainly on occupational grounds. 
This study revealed side effects as a reason why patients default their treatment. From 
their responses it is clear that HIV positive clients on IPT experience side effects which 
make them believe that the Isoniazid  is worsening their condition. The concomitant use 
of anti-tuberculosis drugs with other drugs like ARV’s could lead to unwanted side 
effects which can significantly influence defaulting. It is possible that minor adverse 
effects, which did not pose a danger in the clinician’s view, nevertheless resulted in 
discomfort and contributed to a patients’ decision not to continue treatment (Phillip, 
LoBue, Kathleen, Moser, 2003:445). This finding confirmed the findings of (Fry, 
Khoshnood, Vdovichenko, Granskaya, Sazhin, Shpakovskay, 2005:1030) which 
showed that the concurrent use of HIV medications with TB drugs increases the side 
effects associated with TB chemotherapy. Combining antiretroviral and TB drugs means 
taking many pills daily. This can be difficult and challenging to most patients. 
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In addition, (Chang, 2004:1125) in Hong Kong and (Ali, 2002:577) in Ethiopia find 
treatment side effects to be associated with default. Soriano (2002) in a qualitative study 
in Mutia, Zamboanga del Norte likewise stressed that most of those who defaulted did 
so because of inability to deal with drug’s adverse effects. She further stressed that 
defaulters perceived that the health benefits of undergoing treatment were not worth 
suffering the negative side effects of the medicine. That long term goals of cure and 
recovery were disregarded by defaulters for the immediate goal of seeking relief from 
the discomfort brought about by the side effects of medication. 
In this study participant’s responses showed that negligence by nurses caused some 
clients to default on their medication. This finding is in line with the findings of 
Guillaume-Signoret, 2006:557 and Uwah, Oyenuga; Ekong, & Joshua, 2006b:76) that 
inadequate counseling and information provision by health personnel were the cause of 
TB treatment default. In addition (Selig, Belo, Teixeira, Cunha, Brito, Sanches, Luna, 
Muller, Gamba, Belo, Vento & Trajman, 2003:857) identified negative attitude of 
healthcare professionals toward TB clients leads to non-adherence with treatment. 
The other reason that respondents pointed out includes stopping treatment because 
they were still in denial about their HIV status. Lack of privacy in the TB clinic affect 
treatment seeking behavior of TB clients because of the stigma attached to the disease 
and its associated social problems. Stigma or feeling uncomfortable to take drug in front 
of others was one of the factors for not adhering to IPT. In Ghana, (Dodor, 2004:1340) 
found that clients appeared to be ashamed of their condition. This finding confirmed the 
findings of (Johanson, Diwan , Huong  & Ahlberg, 1996:180) that patients concealed 
their TB status from family members and friends to avoid social isolation and to protect 
their dignity. In addition, Rennie et al., (2007:731) and Munseri et al., (2008:1039) found 
low adherence to preventive INH treatment because of the fear of stigma. 
Another reason for defaulting revealed in the study is the ignorance of clients. Some 
clients do not understand the importance of taking TB treatment or how it may affect 
them. 
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5.2.3 Quality of services provided 
 
According to all respondents they have received poor services in terms of not receiving 
information on reporting when going away or sending someone to take medication if 
they are unable to do so. This finding substantiates the finding of Uwah, Oyenuga, 
Ekong, & Joshua, 2006b) who found that inadequate counseling as well as poor service 
delivery and attitude of health care providers cause clients to default treatment. In fact, 
a case control study carried out in Rio de Janeiro, Brazil revealed that most clients 
default treatment because they do not feel comfortable with doctors, their blood 
pressure is not checked and health care providers do not give them cards indicating 
review date (Salles, Conde, Cunha, Calcada, Menezes, Sa & Kritski, 2004;320). 
In addition, a study in Ghana (Dodor & Afenyadu, 2005:829) found that 44% of client 
who completed treatment admitted good clients’ provider interaction as the main 
motivating factor for completion of treatment. Similarly, a study in the Philippines (Auer, 
Sarol, Tanner & Weiss, 2000:650) found that a cordial relationship between patients 
and health staff enhances an effective treatment in TB clients. However, some studies 
(Teckle, Mariam, & Ali, 2002:577; Jaiswal et al., 2003:625; Gopi, Vasantha, Muniyandi, 
Chandrasekaran, Balasubramanian, Shargie & Lindtjorn, 2007:68) have shown that  
poor client provider interaction influences defaulting. 
The majority of the respondents had never had a visit from the community service 
workers to enquire why they stopped taking medication. It is very important for 
community services to visit client and enquire about their health. Some client may be ill 
which hinders their going to the clinic for their medication. If the community workers visit 
their client they will identify problems or reasons why a client has stopped taking 
medication and find solutions on how to help the client. This finding is in conformity with 
the finding by some studies which suggested that home visits improved adherence 
(Aisu, Raviglione & van Praag, 1995:269; Sanmarti, Megias & Gomez, 1993:29). 
Therefore, if possible, home visits should be used to follow-up the defaulters. 
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From the respondents’ view one can note that some were given medication without an 
explanation of the duration and what it is used for. Proper communication between the 
health worker and the client is vital in order for clients to understand their condition and 
treatment. This finding confirms with a study conducted in Senegal by (Hane, Thiam, 
Fall, Vidal, Diop & Ndir, 2007:542) which affirmed that there was no proper 
communication between client and healthcare providers regarding diagnosis, 
registration and during continuity of treatment. Communication is therefore vital for 
proper treatment management and follows up. The low literacy levels and staff 
shortages in rural settings might also hinder proper and efficient information regarding 
the discharge of TB clients, which could be contributing to poor treatment follow ups 
and, consequently, defaulting on treatment. 
5.2.4 Knowledge about the treatment 
 
Almost a third of respondents did not know the duration of their treatment. On the other 
hand those who knew about the duration of the treatment did not know other information 
about the treatment such as the use of yellow pills for pain, what caregivers are, the 
importance of taking the medication and the consequences, information about side 
effects and getting medication in another town when one changes residence. This 
showed that most of the clients did not have knowledge about TB which led some to 
default. This finding is in line with other studies which found that poor knowledge about 
treatment regimens and clients’ perception of benefits obtained from therapy was 
significantly associated with non-adherence (Rowe et al., 2005:265; Alcabes, 
2006:1195; Becker, 2000:325). Knowledge about the regimen and the disease has 
significant association with adherence which was inconsistent with the study conducted 
in Uganda (Wilkinson, 2005:625). A cross-sectional study in South Africa also showed 
no significant association between clients’ knowledge about the treatment and the 
disease with adherence (Szakacs, Wilson, Cameron, Clark, Kocheleff, Muller & 
McCarthy, 2006:76). 
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5.3 Application of the Theoretical Framework 
According to the theory of planned behavior, intention to perform a behavior is the 
central component in determining the behavior. Intent is influenced by attitudes, 
subjective norms and perceived control (Kerr, Weitkunat  & Morreti, 2005) Adhering to 
the prophylactic treatment of isoniazid for HIV positive clients is the behavior. The 
decision the client has to take to comply with prophylactic treatment is the intention. In 
terms of the TPB model, intention is influenced by the client’s attitude to complete the 
treatment as well as the extent to which his supporters, family and health care workers 
wishes him to finish the course of treatment.  The findings of the study confirmed that 
behavior influenced clients’ adherence to the IPT program. 
5.4 Future Research 
 
The researcher recommends that this kind of research could also be done for the whole 
Eastern Cape Province to get the full understanding of why people default IPT, as this 
study focused in the King Williams Town area which is mostly urban.  
5.5 Recommendations 
 
Respondents identified some suggestions that should help deal with the problems of 
defaulting. Those recommendations should be adhered to. The following are additional 
recommendations by the researcher: 
 Establishing good rapport between clients and health care providers.  
 Team building activities for health workers should be done to improve positive 
attitudes towards the clients thereby buying back trust.in health care systems. 
 To minimize non-adherence due to migration, at the time of enrolment, 
movement potential should be assessed, adequate contact information about the 
programme should be provided to the participants, and arrangement should be 
made so that those who migrate can collect their supply of drugs in advance. 
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  Health care providers should recognize and understand HIV positive clients on 
IPT differences, and treatment should be offered based on the individual’s needs 
and in context with their concerns. Workshops and in- service trainings for health 
workers on IPT, its benefits and existing guidelines should be run periodically. 
 A system to monitor and evaluate the implementation of collaborative TB/HIV 
activities including the provision of IPT should be established. 
 Client monitoring and education should be emphasized and practiced by health 
professionals. 
5.6 Limitations of the Study 
 
The researcher identified the following limitations in the study: 
 The study was restricted to the King Williams Town area of the Buffalo City 
Metropolitan Municipality. Accordingly, the findings cannot be generalized to 
other municipalities or the whole country. 
 The population for this study was generated from the public health facility, HIV 
positive clients on IPT not registered at the clinic but residing in the district were 
therefore not included. 
 The study was conducted within the public health facilities meaning that the 
clients at private facilities were not included as the study was limited to public 
health facilities. 
 
5.7 Conclusion 
 
In conclusion, this qualitative study aimed at exploring and describing the lived 
experiences of HIV positive clients defaulting isoniazid preventive therapy services. The 
emphasis was on the factors leading clients to default. From the respondents’ 
responses it can be noted that work and family related issues, ignorance of patients, 
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side effects, and negligence of nurses and denial of HIV status were identified as 
reasons for defaulting. Having knowledge about the treatment and health providers’ 
attitudes to patients also played a role in patients defaulting in their treatment. Many 
suggestions were then put forward by the respondents to curb defaulting among 
patients. These included the use of text reminders, not to discrimination HIV patients 
because of their status, to use consulting rooms for privacy and also nurses and 
caregivers to control their attitudes when dealing with patients. 
Therefore, having the knowledge on why patients default and what can be done to 
reduce defaulting is of great importance. While TB preventive therapy may not reduce 
the incidence of tuberculosis in the community, it may decrease the mortality rate of HIV 
positive clients by maintaining clients with no signs and symptoms of TB.  
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